Quantitative effect of HLA-DRB1 alleles to ACPA levels in Japanese rheumatoid arthritis: No strong genetic impact of shared epitope to ACPA levels after stratification of HLA-DRB1*09:01

Annals of the Rheumatic Diseases

Volumn 71, Issue 6, 2012, Pages 1095-1097

  Terao, Chikashi ^a   Ikari, Katsunori ^b   Ohmura, Koichiro ^a   Suzuki, Taku ^b   Iwamoto, Takuji ^b   Takasugi, Kiyoshi ^c   Saji, Hiroo ^d   Taniguchi, Atsuo ^b   Momohara, Shigeki ^b   Yamanaka, Hisashi ^b   Matsuda, Fumihiko ^a,e   Mimori, Tsuneyo ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c Dohgo Spa Hospital   (Japan)

^d Japanese Red Cross Kanto Koshinetsu Block Blood Center   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; EPITOPE; HLA DRB1 ANTIGEN;

ALLELE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; JAPANESE; LETTER; MAJOR CLINICAL STUDY; PATIENT CODING; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOANTIBODIES; EPITOPES; HLA-DRB1 CHAINS; HUMANS; PEPTIDES, CYCLIC;

EID: 84862779332     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-200907     Document Type: Letter

References (10)

1. van Venrooij WJ, Hazes JM, Visser H. Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis. Neth J Med 2002;60:383-8. (Pubitemid 39089354)
2. Schellekens GA, Visser H, de Jong BA, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000;43:155-63. (Pubitemid 30368225)
3. van Jaarsveld CH, ter Borg EJ, Jacobs JW, et al. The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis. Clin Exp Rheumatol 1999;17:689-97.
4. van der Woude D, Lie BA, Lundström E, et al. Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1* 1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in four European populations. Arthritis Rheum 2010;62:1236-45.
5. Gorman JD, Lum RF, Chen JJ, et al. Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients. Arthritis Rheum 2004;50:400-12. (Pubitemid 38198824)
6. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:1205-13. (Pubitemid 18005792)
7. Balsa A, Cabezón A, Orozco G, et al. Influence of HLA-DRB1 alleles in the susceptibility of rheumatoid arthritis and the regulation of antibodies against citrullinated proteins and rheumatoid factor. Arthritis Res Ther 2010;12:R62.
8. Ohmura K, Terao C, Maruya E, et al. Anti-citrullinated peptide antibody-negative RA is a genetically distinct subset: a definitive study using only bone-erosive ACPA-negative rheumatoid arthritis. Rheumatology (Oxford) 2010;49:2298-304.
9. Okada Y, Suzuki A, Yamada R, et al. HLA-DRB1*0901 lowers anti-cyclic citrullinated peptide antibody levels in Japanese patients with rheumatoid arthritis. Ann Rheum Dis 2010;69:1569-70.
10. Payami H, Joe S, Farid NR, et al. Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. Am J Hum Genet 1989;45:541-6. (Pubitemid 19261441)